IBM’s Watson computer isn’t having a hard time securing new jobs in this tough job market. Citigroup recently hired the computer for a risk analysis project and now the supercomputer is breaking into the health industry. IBM and Memorial Sloan-Kettering Cancer Center (MSKCC) are joining forces to develop a new tool that will provide oncologists and other medical professionals with the most up-to-date cancer data. The data will then be used to create an individualized cancer diagnostic and treatment plan.
Craig B. Thompson, president and CEO of MSKCC, commented on the partnership.
“The combination of transformational technologies found in Watson with our cancer analytics and decision-making process has the potential to revolutionize the accessibility of information for the treatment of cancer in communities across the country and around the world. Consistent with our mission, the vision is to help better identify and personalize cancer therapies for each individual patient, no matter where that patient may be receiving care. We also expect tremendous new research opportunities to emerge from this collaboration.” Source: MSKCC
The first tool using IBM’s Watson, which will focus on lung, breast and prostate cancers, is already in the development stage. A pilot project including a small group of oncologists will begin later this year with a larger-scale rollout planned for late next year. The project will allow doctors and patients access to the data, regardless of where they live or practice.